20.1402.34% ( +0.460 )
Delay Closed: Nov 16, 16:08:11Financials
H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: GIANT BIOGENE(02367) the Revenue is 3.37 B (-1.19%), Beat estimate;the EBIT is 1.254 B (-15.88%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.37B1.19%
3.34B1.95%
+0.03B0.76%
EBITExceed expectations
1.25B15.88%
1.15B22.87%
+0.10B6.99%
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 19, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
